Dear Colleagues and Friends,

I am delighted to invite you to the 24th Symposium of the International Immunocompromised Host Society (ICHS), which will be held from May 14-17, 2026, in Houston, Texas, USA.

Building on the long-standing tradition of excellence in ICHS Symposia since 1980 and our growing membership, our Program Committee is preparing a state-of-the-art scientific program that will cover the latest advancements in infections and immunodeficiency, bringing together leading experts from around the world.

This Symposium will continue to provide a unique platform for both basic scientists, clinicians, and trainees to discuss groundbreaking research, innovative diagnostic tools, difficult to manage clinical cases, and emerging therapies that impact the care of immunocompromised patients.

Attendees will have the opportunity to engage in cutting-edge discussions, interactive sessions, and networking opportunities with the experts and industry leaders. Our corporate partners will also showcase the latest developments in diagnostics and therapeutics, offering valuable insights into the future of patient care.

Houston, a dynamic and diverse city, is home to world-class medical and research institutions and offers a vibrant cultural experience. From renowned museums and space exploration to outstanding culinary and entertainment options, Houston promises an enriching experience beyond the scientific sessions.

Mark your calendars for May 14-17, 2026, and stay updated by visiting our Symposium website at www.ichs.org.
You can also follow us on social media for the latest updates.

We look forward to welcoming you to Houston for an unforgettable Symposium!

Warmest regards,

Roy F. Chemaly

Roy F. Chemaly, MD, MPH, FIDSA, FACP, FESCMID
President, International Immunocompromised Host Society
Professor and Chair
G. P. Bodey, Sr. Distinguished Professorship in Infectious Diseases
Director, Clinical Virology Research
MD Anderson Cancer Center
Department of Infectious Diseases, Infection Control and Employee Health
Medicine, Infectious Diseases
The University of Texas, MD Anderson Cancer Center
Houston, Texas USA